Lymphatic mapping and sentinel lymph node biopsy in breast cancer

European Journal of Nuclear Medicine

Volumn 26, Issue SUPPL., 1999, Pages

  Nieweg, Omgo E ^a   Jansen, Liesbeth ^a   Valdés Olmos, Renato A ^a   Rutgers, Emiel J Th ^a   Peterse, Johannes L ^a   Hoefnagel, Kees A ^a   Kroon, Bin B R ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Breast neoplasms; Lymphadenectomy; Probe; Sentinel node; Staging

Indexed keywords

RADIOPHARMACEUTICAL AGENT;

BREAST CANCER; CANCER STAGING; CONFERENCE PAPER; HUMAN; LYMPH FLOW; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; VITAL STAIN;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM;

EID: 0032951582     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050572     Document Type: Conference Paper

References (39)

1. Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Bull 1894-1895; 4: 297-323.
2. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985; 5: 17-21.
3. Morrow M. Role of axillary dissection in breast cancer management. Ann Surg Oncol 1996; 3: 233-234.
4. Cascinelli N, Greco M, Bufalino R, Clemente C, et al. Prognosis of breast cancer with axillary node metastases after surgical treatment only. Eur J Cancer Clin Oncol 1987; 23: 795-799.
5. Siegel BM, Mayzel KA, Love SM. Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 1990; 125: 1144-1147.
6. Kissin MW, Querci della Rovere G, Easton D, et al. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986; 73: 580-584.
7. Morton DL, Wen D, Wong JH, et al. Technical details of intra-operative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
8. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220: 759-767.
9. Kapteijn BAE, Nieweg OE, Peterse JL, et al. Identification and biopsy of the sentinel node in breast cancer. Ear J Surg Oncol 1998; 24: 427-430.
10. Roumen RMH, Valkenburg JGM, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997; 23: 495-502.
11. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997; 3: 336-340.
12. Van de Ent FWC, Kengen RAM, Van der Poll HAG, et al. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Kur J Surg Oncol, in press.
13. Schneebaum S, Stadler Y, Cohen M, Baron J, Skornik Y. Sentinel lymph node localization in breast cancer - a feasibility study. 49th Annual Meeting Soc Surg Oncol, Atlanta, March 21-24 1996 (abstract).
14. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 226: 645-653.
15. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-127.
16. Vries J de, Doting MHE, Nieweg OE, et al. Combined detection technique of radioactive tracer and blue dye for sentinel lymph node biopsy in breast cancer. 51st Annual Meeting Soc Surg Oncol & World Fed Surg Oncol Soc Congress. San Diego, March 26-29 1998 (abstract).
17. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymphnode in breast cancer. Lancet 1997; 349: 1668-1669.
18. McMasters KM, Giuliano AE, Ross MI, et al. Sentinel-lymphnode biopsy for breast cancer - not yet the standard of care. N Engl J Med 1998; 339: 990-995.
19. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-401.
20. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345-2350.
21. st International Congress on the Sentinel Mode in Diagnosis and Treatment of Cancer. Amsterdam, April 7-10 1999 (abstract).
22. Jansen L, Nieweg OE, Valdes Olmos RA, et al. Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy. Eur J Surg Oncol 1998; 24: 445-446.
23. Uren RF, Howman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36: 1775-1780.
24. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998; 339: 941-946.
25. Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 1998; 82: 1704-1708.
26. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-1822.
27. Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998; 5: 126-130.
28. Krag D, Weaver D, Alex J, et al. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. 47th Annual Meeting Soc Surg Oncol. Houston, March 17-20 1994 (abstract).
29. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. The Lancet 1997; 349: 1864-1867.
30. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-283.
31. Koller M, Barsuk D, Zippel D, et al. Sentinel lymph node involvement - a predictor for axillary node status with breast cancer - has the time come? Eur J Surg Oncol 1998; 24: 166-168.
32. Gill PG, Hall VE, Kirkwood I, et al. Lymphscintigraphy for locating the sentinel lymph node in patients with breast cancer. Breast 1997; 6: 225 (abstract).
33. Crossin JA, Johnson AC, Stewart PB, et al. Gamma-probeguided resection of the sentinel lymph node in breast cancer. Am Surg 1998; 64: 666-668.
34. Miner TJ, Shriver CD, Jaques DP, et al. Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol 1998; 5: 315-321.
35. Horgan K, Mancie-Jones B, Madan M, et al. Axillary sentinel node identification in breast cancer with dye injection alone. Br J Surg 1998; 85, Suppl 51-52 (abstract).
36. Flett MM. Going JJ, Stanton PD, et al. Sentinel node localization in patients with breast cancer. Br J Surg 1998; 85: 991-993.
37. Reuhl T, Kaisers H, Markwardt J, et al. Axillaausräumung bei klinisch nodal-negativem Mammakarzinom. Kann die Indikation durch "sentinel node" Nachweis individualisiert werden? Dtsch Med Wochenschr 1998; 123: 583-587.
38. Fölscher DJ, Langman G, Panieri E, et al. Sentinel axillary lymph node: helpful in axillary management in patients with breast cancer? Br J Surg 1997; 84: 1586 (abstract).
39. Sandrucci S, Bello M, Danese S, et al. Predictive value of the sentinel node biopsy in axillary staging of T1-T2 breast cancer. A preliminary experience. Joint Meeting on Senology and Eur Soc Mastol: 2nd Int Conf. March 20-21 1997 (abstract).